Iran Medical Council Journal of Iranian Medical Council 2645-338X 5 3 2022 07 01 Relationship Between Cardiac and Liver Markers with In-hospital Mortality in COVID-19 Patients 454 461 159836 10.18502/jimc.v5i3.10941 EN Hedieh Moradi Tabriz department of pathology, TUMS Maryam Dargahi department of pathology,TUMS Mahnaz Montazeri department of internal medicine, TUMS Elham Nazar Department of pathology, Sina hospital, TUMS Journal Article 2022 01 04 Abstract Background: COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections has turn into a pandemic and has extended all over the world. Since the virus has the potential ability to severely impair heart and liver, analyzing the biochemical parameters is a suitable approach for clinicians to assess the outcome. Methods: This study was conducted along with 614 recognized COVID-19 patients. All samples were from Emergency department of Sina Hospital in Tehran, Iran, from February to May, 2020. Results: A total of 614 COVID-19 patients with mean age of 57.8 years (16-94 years) consisting of 385 (62.7%) male and 229 (37.2%) female were studied. Patients with COVID-19 had no significant difference between cardiac and liver parameters on the presentation and discharge time (p-value≥0.05). Patients with COVID-19 had significant correlation in Lactate dehydrogenase (LDH), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), and Total Bilirubin with recovery and mortality outcome (p-value≤0.05). Also, high sensitivity cardiac Troponin-I, LDH, AST, and ALT in patients with COVID-19 were significantly associated with high in-hospital mortality (p-value<0.05). Conclusion: Several laboratory parameters may ease the evaluation of COVID-19 in-hospital mortality. Cardiac and liver parameters are critical in assisting COVID-19 cases.

https://www.jimc.ir/article_159836_0629941bb781c38a77e887052e0bcef0.pdf